NCT02888262Active, not recruiting
The Bipolar Illness Onset Study (the BIO Study)
Source: ClinicalTrials.gov · Last updated 19 Oct 2023
Brief summary (registry, in English)
This longitudinal study aims to identify 1) a composite blood-based biomarker, 2) a composite electronic Smartphone-based biomarker and 3) a neurocognitive signature for bipolar disorder
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 700 (actual)
- First submitted
- 24 Aug 2016
- Start date
- 1 Jan 2016
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
- Diseases
- Bipolar disorder
- NCT number
- NCT02888262
What you commit to
- Study type: Observational
- Participants enrolled: 700
- From 1 Jan 2016 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Significant physical disorders
- Schizophrenia or related disorders
Who the study is looking for
- Newly diagnosed/first episode bipolar patients,
- First-generation relatives (siblings and children aged 15 to 40 years) to the recruited newly diagnosed/first episode bipolar patients.
- Age- and gender matched sample of healthy individuals without a first-generation family history of effective disorders
Age in the registry: 16 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Psychiatric Center Copenhagen Coordinator of this site? Confirm its status | Copenhagen | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.